The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
about
Opioid Drugs in Patients With Liver Disease: A Systematic ReviewFast track anesthesia for liver transplantation: Review of the current practiceRole of supportive care for terminal stage hepatocellular carcinomaOpioid metabolism2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaRegulation of uridine diphosphate glucuronosyltransferase during the acute-phase responseOral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trialPain management in the cirrhotic patient: the clinical challenge.A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology.Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.Joining the DoTS: new approach to classifying adverse drug reactionsNonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.New developments in glucuronidation research: report of a workshop on "glucuronidation, its role in health and disease".Hepatic resection is associated with reduced postoperative opioid requirementPharmacology of morphine in obese patients: clinical implications.The Promises of Quantitative Proteomics in Precision MedicineImplications of opioid analgesia for medically complicated patients.Analgesia for the cirrhotic patient: a literature review and recommendations.The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendationsVariations of pharmacokinetics of drugs in patients with cirrhosis.Drug metabolism and liver disease: a drug-gene-environment interaction.Survival Implications of Opioid Use Before and After Liver Transplantation.No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.Spinal morphine in nonmalignant chronic pain: a retrospective study in 39 patients.Opioid use in chronic pain.[Pharmacotherapy of cancer pain : 2. Use of opioids.].Cancer pain management. Current strategy.Prediction of morphine dose in humans.Factors and conditions affecting the glucuronidation of oxazepam.The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy.Morphine metabolism in neonates and infants.Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine.Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.Effects of liver disease on the disposition of the opioid antagonist nalmefene.Opioid misuse in gastroenterology and non-opioid management of abdominal pain.Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.Role of enterohepatic recirculation in drug disposition: cooperation and complications.
P2860
Q26743429-5B60783B-9D1A-4C2D-9781-C78D4A05261EQ26783852-26C82A11-389D-408F-B1CD-A2BDC5690112Q26822263-038E1704-1AD0-474C-BC92-4FFC83ABCCD6Q28250437-6AC7ADB8-C5C5-4546-90F4-7B4BBFE296A0Q28392783-2AEFD280-FB58-4755-BACC-83F321A06560Q28394414-D7B981A0-2FFF-4CCE-BC9B-8ACC3BC161F2Q28582517-808E4949-B311-47CD-BB02-F6019BAAC00FQ28650251-77ACB24D-1269-4C36-B160-EF1585CF1291Q30494286-A2FDF5AF-C1CD-44AC-8155-1A90EE9224F0Q33532744-4BE82F31-5D1B-4A70-8147-4E8A5117CAAAQ34230318-6F5EE2A4-F653-4F6D-B51D-119CCA61393AQ34819051-47AED8D9-2E34-4E19-8E03-EB934451ED5CQ35590133-DE361A5C-970A-4B80-A713-DD871ABDE2BBQ35689076-4DCC6A7A-0D47-4736-81DE-E86E25373E82Q35866790-BDB891DF-5AA2-40F1-A809-016E8A16ADAFQ37229012-5FDFD8C0-C228-4FF0-864A-66D6C3D9496EQ37594760-0852AA0F-6E27-4FCD-ABAB-120715DC1FDEQ37647264-0E8D4F0C-8310-4E8B-8BD3-BD2939157FE9Q37744893-9F9C3630-777D-49F8-9FF2-C61CA5611514Q38189124-613EA171-0D03-4209-A3ED-E22A2C31C7C6Q38283546-9E134A11-8412-4FBC-B6E7-6B7DF42F8734Q38676890-718AA5F3-6262-47E8-A84E-90ED3BC3CE99Q39037269-6D4C38F7-61B5-40AF-B93D-8EB09DA4754CQ39062029-21768BF3-3463-4E2B-8699-96B536576BC3Q39365827-E9217FE3-5C28-48E1-A7E8-95513821B814Q39405635-3BA8FCF9-1429-4998-84EC-50B53BE75DB1Q39459466-339D040D-8B49-4216-98EA-64EAC66AB81EQ39477920-30E6F4EC-B02D-433B-9E34-B5E735F1FEB6Q39489632-20F32FD2-EC88-4E8A-8884-8596B39B0563Q39668518-4801E90A-F565-487F-9242-319F3F4701CEQ40866617-E5BC496C-A51B-482F-B9DE-E982AF47A87AQ41170052-F97EC5AE-C104-4282-B67B-B342F3CBA951Q41234341-334BA8F2-3032-4E26-A549-09FD0AC98A6AQ43224470-0FB89628-C912-4A57-9E5C-C809CAADA92AQ43968416-B6BB5913-6423-4221-9FF8-EDBA228584C9Q43997719-31CCF29B-5C7D-4A97-B97E-AD1A7343940FQ44344935-B42B8FB5-3526-404A-B89D-AE0E635EFA1BQ44350905-DC390408-BBB2-47D7-87EB-8F2F847F3AB7Q44476215-CD039309-8BC7-4527-A387-AD0B8AD94AAAQ46578287-7541E60E-DF90-4DF5-B39A-AAA7709C673F
P2860
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@ast
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@en
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@nl
type
label
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@ast
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@en
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@nl
prefLabel
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@ast
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@en
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@nl
P2093
P2860
P1476
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03638.X
P407
P577
1990-03-01T00:00:00Z